169 related articles for article (PubMed ID: 24297264)
1. Acquired pure red cell aplasia due to treatment with clopidogrel: first case report.
Li G; Li ZQ; Yang QY; Yang JD
J Thromb Thrombolysis; 2014; 38(2):215-7. PubMed ID: 24297264
[TBL] [Abstract][Full Text] [Related]
2. [A case of ticlopidine induced acute cholestatic hepatitis and pure red cell aplasia].
Lee JY; Park EB; Ahn JH; Suh SJ; Jung YK; Kim JH; Shin BK; Yang JH; Yeon JE; Byun KS
Korean J Hepatol; 2008 Mar; 14(1):102-7. PubMed ID: 18367863
[TBL] [Abstract][Full Text] [Related]
3. Clopidogrel Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients Treated With Percutaneous Coronary Intervention: Results of the CLOTILDIA Study (Clopidogrel High Dose Versus Ticagrelor for Antiplatelet Maintenance in Diabetic Patients).
Mangiacapra F; Panaioli E; Colaiori I; Ricottini E; Lauria Pantano A; Pozzilli P; Barbato E; Di Sciascio G
Circulation; 2016 Sep; 134(11):835-7. PubMed ID: 27619717
[No Abstract] [Full Text] [Related]
4. The challenge of monitoring platelet response after clopidogrel.
Serebruany VL; Goto S
Eur Heart J; 2008 Dec; 29(23):2833-4. PubMed ID: 18977768
[No Abstract] [Full Text] [Related]
5. Comparison of effects of clopidogrel versus ticlopidine on platelet function in patients undergoing coronary stent placement.
Gawaz M; Seyfarth M; Müller I; Rüdiger S; Pogatsa-Murray G; Wolf B; Schömig A
Am J Cardiol; 2001 Feb; 87(3):332-6, A9. PubMed ID: 11165971
[TBL] [Abstract][Full Text] [Related]
6. [Long-term effect of clopidogrel do exist--but hardly worth the costs].
Hansen O
Lakartidningen; 2003 Oct; 100(41):3216-7. PubMed ID: 14587263
[No Abstract] [Full Text] [Related]
7. Effect of cilostazol addition or clopidogrel doubling on platelet function profiles in diabetic patients undergoing a percutaneous coronary intervention.
Ha SJ; Kim SJ; Hwang SJ; Woo JS; Kim W; Kim WS; Kim KS; Kim MK
Coron Artery Dis; 2013 Dec; 24(8):690-7. PubMed ID: 24152567
[TBL] [Abstract][Full Text] [Related]
8. Detection of clopidogrel hyporesponsiveness using a point-of-care assay and the impact of additional cilostazol administration after coronary stent implantation in diabetic patients.
Yang TH; Kim DI; Kim DK; Jang JS; Kim U; Seol SH; Kim DK; Hong GR; Park JS; Shin DG; Kim YJ; Cho YK; Nam CW; Hur SH; Kim KB; Kim DS
Korean J Intern Med; 2011 Jun; 26(2):145-52. PubMed ID: 21716590
[TBL] [Abstract][Full Text] [Related]
9. Lack of correlation between platelet reactivity and glycaemic control in type 2 diabetes mellitus patients treated with aspirin and clopidogrel.
Mangiacapra F; Peace AJ; Wijns W; Barbato E
J Thromb Thrombolysis; 2011 Jul; 32(1):54-8. PubMed ID: 21221715
[TBL] [Abstract][Full Text] [Related]
10. Antithrombotic potency of ticagrelor versus clopidogrel in type-2 diabetic patients with cardiovascular disease.
Zafar MU; Baber U; Smith DA; Sartori S; Contreras J; Rey-Mendoza J; Linares-Koloffon CA; Escolar G; Mehran R; Fuster V; Badimon JJ
Thromb Haemost; 2017 Oct; 117(10):1981-1988. PubMed ID: 28837213
[TBL] [Abstract][Full Text] [Related]
11. Effectiveness of clopidogrel and aspirin versus ticlopidine and aspirin in preventing stent thrombosis after coronary stent implantation.
Moussa I; Oetgen M; Roubin G; Colombo A; Wang X; Iyer S; Maida R; Collins M; Kreps E; Moses JW
Circulation; 1999 May; 99(18):2364-6. PubMed ID: 10318654
[TBL] [Abstract][Full Text] [Related]
12. Aspirin, ticlopidine, and clopidogrel in acute coronary syndromes: underused treatments could save thousands of lives.
Tan WA; Moliterno DJ
Cleve Clin J Med; 1999; 66(10):615-8, 621-4, 627-8. PubMed ID: 10598366
[TBL] [Abstract][Full Text] [Related]
13. Fatal liver injury associated with clopidogrel.
Kastalli S; El Aïdli S; Zaïem A; ben Abdallah H; Daghfous R
Fundam Clin Pharmacol; 2010 Aug; 24(4):433-5. PubMed ID: 19895648
[TBL] [Abstract][Full Text] [Related]
14. Impact of diabetes mellitus and metabolic syndrome on acute and chronic on-clopidogrel platelet reactivity in patients with stable coronary artery disease undergoing drug-eluting stent placement.
Feldman L; Tubach F; Juliard JM; Himbert D; Ducrocq G; Sorbets E; Triantafyllou K; Kerner A; Abergel H; Huisse MG; Roussel R; Esposito-Farèse M; Steg PG; Ajzenberg N
Am Heart J; 2014 Dec; 168(6):940-7.e5. PubMed ID: 25458659
[TBL] [Abstract][Full Text] [Related]
15. Clopidogrel-associated angioedema.
Fischer TC; Worm M; Groneberg DA
Am J Med; 2003 Jan; 114(1):77-8. PubMed ID: 12543298
[No Abstract] [Full Text] [Related]
16. Platelet function profiles in patients with type 2 diabetes and coronary artery disease on combined aspirin and clopidogrel treatment.
Angiolillo DJ; Fernandez-Ortiz A; Bernardo E; Ramírez C; Sabaté M; Jimenez-Quevedo P; Hernández R; Moreno R; Escaned J; Alfonso F; Bañuelos C; Costa MA; Bass TA; Macaya C
Diabetes; 2005 Aug; 54(8):2430-5. PubMed ID: 16046311
[TBL] [Abstract][Full Text] [Related]
17. Rash with both clopidogrel and ticlopidine in two patients following percutaneous coronary intervention with drug-eluting stents.
Makkar K; Wilensky RL; Julien MB; Herrmann HC; Spinler SA
Ann Pharmacother; 2006 Jun; 40(6):1204-7. PubMed ID: 16684808
[TBL] [Abstract][Full Text] [Related]
18. Antiplatelet profiles of the fixed-dose combination of extended-release dipyridamole and low-dose aspirin compared with clopidogrel with or without aspirin in patients with type 2 diabetes and a history of transient ischemic attack: a randomized, single-blind, 30-day trial.
Serebruany VL; Malinin AI; Pokov AN; Hanley DF
Clin Ther; 2008 Feb; 30(2):249-59. PubMed ID: 18343263
[TBL] [Abstract][Full Text] [Related]
19. Clopidogrel desensitization: case report and review of published protocols.
Owen P; Garner J; Hergott L; Page RL
Pharmacotherapy; 2008 Feb; 28(2):259-70. PubMed ID: 18225971
[TBL] [Abstract][Full Text] [Related]
20. Serum sickness-like reaction associated with clopidogrel.
Phillips EJ; Knowles SR; Shear NH
Br J Clin Pharmacol; 2003 Nov; 56(5):583. PubMed ID: 14651737
[No Abstract] [Full Text] [Related]
[Next] [New Search]
